Guidelines for the development and incorporation of biomarker studies in early clinical trials of novel agents. (Q51779026)
Jump to navigation
Jump to search
scientific article published on 9 March 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Guidelines for the development and incorporation of biomarker studies in early clinical trials of novel agents. |
scientific article published on 9 March 2010 |
Statements
1 reference
Guidelines for the development and incorporation of biomarker studies in early clinical trials of novel agents. (English)
1 reference
Mark J Ratain
1 reference
Janet E Dancey
1 reference
Kevin K Dobbin
1 reference
Susan Groshen
1 reference
J Milburn Jessup
1 reference
Andrew H Hruszkewycz
1 reference
Maria Koehler
1 reference
Ralph Parchment
1 reference
Lalitha K Shankar
1 reference
Walter M Stadler
1 reference
Lawrence D True
1 reference
Amy Gravell
1 reference
Michael R Grever
1 reference
Biomarkers Task Force of the NCI Investigational Drug Steering Committee
1 reference
9 March 2010
1 reference
16
1 reference
6
1 reference
1745-1755
1 reference
Identifiers
1 reference